申请人:Hermann Johannes Cornelius
公开号:US20120309746A1
公开(公告)日:2012-12-06
The present invention relates to the use of novel triazolopyridine derivatives of formula I:
wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
本发明涉及使用以下式I的新型三唑吡啶衍生物:
其中所有变量取代基的定义如本文所述,这些化合物是SYK抑制剂,可用于治疗自身免疫和炎症性疾病。